What does OXYPOINT do?

OXYPOINT is a wholesaler in Niel. Public Limited, started on 6 January 2011, 1 establishment.

What is the address of OXYPOINT?

The registered office of OXYPOINT is located at Galileilaan 15, 2845 Niel.

Is OXYPOINT still active?

No. The CBE lists OXYPOINT with legal situation “Opening faillissement”. The date of the court ruling is published in the Belgian Official Gazette; the register does not carry it.

Is OXYPOINT registered on Peppol?

No, OXYPOINT is currently not registered on the Peppol network.

What is the enterprise number of OXYPOINT?

The enterprise number of OXYPOINT is BE0832604943.

When was OXYPOINT founded?

OXYPOINT was founded on 6 January 2011.

Who are the directors of OXYPOINT?

According to the 2024 annual accounts, the directors of OXYPOINT are: COFIMA, P& L PROJECTS, GEO-PHARM, STARTEGICA, Innovamus.

Is OXYPOINT a reliable company?

Databakkes does not pass judgement; this is what the sources say: Opening faillissement according to the CBE, started on 6 January 2011; 4 annual accounts filed, latest fiscal year 2024; 5 directors known from the annual account.

How much profit did OXYPOINT make in 2024?

OXYPOINT recorded a loss after taxes of € 624,006 in financial year 2024.

What is the revenue of OXYPOINT?

In its most recent annual accounts (2024), OXYPOINT reported revenue of € 354,827.

How much does an employee at OXYPOINT earn?

The average wage cost per full-time employee at OXYPOINT was € 77,900 in 2024: staff costs of € 335,164 for 4.3 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does OXYPOINT have?

According to the 2024 annual accounts, OXYPOINT has 4.3 full-time equivalents (FTE).

Does OXYPOINT have a website?

Yes, OXYPOINT has a website at oxypoint.eu.

OXYPOINT (Public Limited) - Niel - BE0832604943

Dossier OXYPOINT, printed on 29 October 2026 from databakkes.be/en/0832604943/oxypoint. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Negative equity NBB

More debt than assets in 2 of the last 4 fiscal years.
Two loss years in a row NBB

Negative result in 2023 and 2024.
Tight liquidity NBB

Cash and receivables cover 29 % of short-term debt in 2024; threshold 65 %.
Busy address KBO

21 other companies have their registered office at the same address; threshold 10.
Legal situation KBO

Opening faillissement according to the CBE.

Financials

Financial year 2024

OXYPOINT from Niel, company number BE0832604943, closed financial year 2024 with a result of € -624,006 after tax. For that financial year OXYPOINT recorded revenue of € 354,827 and equity of € -747,099. Compared with financial year 2023, the result moved from € -604,831 to € -624,006. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 15, 2025.

What it is worth Caution

€ -747,099

▼ € 624,006 vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -624,006

▼ 3 % more loss than in 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 75,914

▼ 41% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -2.1 million.

People and assets in 2024

Full-time equivalents

4.3

▲ 1 vs 2023

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 335,164

▲ 113% vs 2023

€ 77,900 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 3,622

▲ 43% vs 2023

Book value of vehicles, furniture and equipment.

Debts at end 2024

Bank debt ≈ 12 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 1.2 million

▲ 56% vs 2023

€ 101,376 is repaid this year. At this pace the long-term loan is gone in ≈ 12 years.

Owed to suppliers

€ 388,121

▲ 6% vs 2023

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 54,725

▲ 213% vs 2023

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Revenue	€ 302,161 Revenue 2021: € 302,161 First fiscal year in the series	€ 144,679 Revenue 2022: € 144,679 ▼ 52% vs 2021 (€ 302,161) Unfavourable step	€ 222,466 Revenue 2023: € 222,466 ▲ 54% vs 2022 (€ 144,679) Favourable step	€ 354,827 Revenue 2024: € 354,827 ▲ 59% vs 2023 (€ 222,466) Favourable step	▲ 59%
Gross margin	€ -152,980 Gross margin 2021: € -152,980 First fiscal year in the series	€ -437,164 Gross margin 2022: € -437,164 ▼ € 284,185 vs 2021 (€ -152,980) Unfavourable step	€ -213,139 Gross margin 2023: € -213,139 ▲ € 224,026 vs 2022 (€ -437,164) Favourable step	€ -40,921 Gross margin 2024: € -40,921 ▲ € 172,218 vs 2023 (€ -213,139) Favourable step	▲ € 172,218
Profit after taxes	€ -515,912 Profit after taxes 2021: € -515,912 First fiscal year in the series	€ -846,680 Profit after taxes 2022: € -846,680 ▼ € 330,768 vs 2021 (€ -515,912) Unfavourable step	€ -604,831 Profit after taxes 2023: € -604,831 ▲ € 241,848 vs 2022 (€ -846,680) Favourable step	€ -624,006 Profit after taxes 2024: € -624,006 ▼ € 19,175 vs 2023 (€ -604,831) Unfavourable step	▼ € 19,175
Equity	€ 1,328,419 Equity 2021: € 1,328,419 First fiscal year in the series	€ 481,739 Equity 2022: € 481,739 ▼ 64% vs 2021 (€ 1,328,419) Unfavourable step	€ -123,092 Equity 2023: € -123,092 ▼ € 604,831 vs 2022 (€ 481,739) Unfavourable step	€ -747,099 Equity 2024: € -747,099 ▼ € 624,006 vs 2023 (€ -123,092) Unfavourable step	▼ € 624,006
Total debts	€ 473,642 Total debts 2021: € 473,642 First fiscal year in the series	€ 1,330,741 Total debts 2022: € 1,330,741 ▲ 181% vs 2021 (€ 473,642) Unfavourable step	€ 1,732,350 Total debts 2023: € 1,732,350 ▲ 30% vs 2022 (€ 1,330,741) Unfavourable step	€ 2,143,708 Total debts 2024: € 2,143,708 ▲ 24% vs 2023 (€ 1,732,350) Unfavourable step	▲ 24%
Cash	€ 330,533 Cash 2021: € 330,533 First fiscal year in the series	€ 361,624 Cash 2022: € 361,624 ▲ 9% vs 2021 (€ 330,533) Favourable step	€ 128,149 Cash 2023: € 128,149 ▼ 65% vs 2022 (€ 361,624) Unfavourable step	€ 75,914 Cash 2024: € 75,914 ▼ 41% vs 2023 (€ 128,149) Unfavourable step	▼ 41%
Land & buildings	€ 1,237 Land & buildings 2021: € 1,237 First fiscal year in the series	-	€ 657 Land & buildings 2023: € 657 First fiscal year in the series	€ 500 Land & buildings 2024: € 500 ▼ 24% vs 2023 (€ 657) Unchanged	▼ 24%
Retained profit	€ -512,966 Retained profit 2021: € -512,966 First fiscal year in the series	€ -843,734 Retained profit 2022: € -843,734 ▼ € 330,768 vs 2021 (€ -512,966) Unfavourable step	€ -1,448,565 Retained profit 2023: € -1,448,565 ▼ € 604,831 vs 2022 (€ -843,734) Unfavourable step	€ -2,072,571 Retained profit 2024: € -2,072,571 ▼ € 624,006 vs 2023 (€ -1,448,565) Unfavourable step	▼ € 624,006
Bank debt	€ 0 Bank debt 2021: € 0 First fiscal year in the series	€ 300,000 Bank debt 2022: € 300,000 Unchanged (€ 0) Unfavourable step	€ 778,613 Bank debt 2023: € 778,613 ▲ 160% vs 2022 (€ 300,000) Unfavourable step	€ 1,215,183 Bank debt 2024: € 1,215,183 ▲ 56% vs 2023 (€ 778,613) Unfavourable step	▲ 56%
Balance sheet total	€ 1,802,061 Balance sheet total 2021: € 1,802,061 First fiscal year in the series	€ 1,812,480 Balance sheet total 2022: € 1,812,480 ▲ 1% vs 2021 (€ 1,802,061) Unchanged	€ 1,609,258 Balance sheet total 2023: € 1,609,258 ▼ 11% vs 2022 (€ 1,812,480) Unchanged	€ 1,396,610 Balance sheet total 2024: € 1,396,610 ▼ 13% vs 2023 (€ 1,609,258) Unchanged	▼ 13%
Employees (FTE)	2.4 Employees (FTE) 2021: 2.4 First fiscal year in the series	3.3 Employees (FTE) 2022: 3.3 ▲ 0.9 vs 2021 (2.4) Unchanged	3.3 Employees (FTE) 2023: 3.3 Unchanged (3.3) Unchanged	4.3 Employees (FTE) 2024: 4.3 ▲ 1 vs 2023 (3.3) Unchanged	▲ 1

Key figures of OXYPOINT, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to OXYPOINT?

What happened at OXYPOINT in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

OXYPOINT is active according to the CBE. Legal situation: Opening faillissement.

2027 P& L PROJECTS stepped down as director. NBB
2027 STARTEGICA stepped down as director. NBB
Jul 15, 2025 New annual accounts for financial year 2024: loss of € 624,006. Source: NBB ↗
2025 GEO-PHARM stepped down as director. NBB
2024 GEO-PHARM became a director. NBB
2024 Innovamus stepped down as director. NBB
2024 COFIMA stepped down as director. NBB
2022 STARTEGICA became a director. NBB

In short

From € 515,912 loss in 2021 to € 624,006 loss in 2024.

Paid € 2,322 in corporate taxes since 2021.

Original PDFs at the National Bank ↗

Management

Participatiemaatschappij Vlaanderen 26.1%

The stake of Participatiemaatschappij Vlaanderen comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

OXYPOINT

The shares are held by Participatiemaatschappij Vlaanderen (26.1%).

Directors

According to the 2024 annual accounts

COFIMA

Director · represented by LUC HANSEN

since 2021 · until 2024

P& L PROJECTS

Director · represented by FRANK PIETERS

since 2022 · until 2027

GEO-PHARM

Director · represented by Thiéry Damien

since 2024 · until 2025

STARTEGICA

Director · represented by Guy Lefever

since 2022 · until 2027

Innovamus

Director · represented by PHILIP HENDRICKX

since 2018 · until 2024

Shareholders

Participatiemaatschappij Vlaanderen

26.1%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Galileilaan 15

2845 Niel

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 21 companies are registered at this address.

All companies at this address →

KARDECO

€ -40,718 gross margin · 2025

ADM

€ 178,215 gross margin · 2023

CAST4ALL

€ -46,308 gross margin · 2025

UBIS

€ 237,171 gross margin · 2025

Hemplab Institute

€ -1,306 gross margin · 2025

+16 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTP oxypoint.eu

Technologies

Nginx

Hosting & Email

Email provider

Microsoft 365

Hosting

COMBELL-AS, BE

Domain

oxypoint.eu

Registrar

Combell NV

Website info

HTTPS Nee

Features

Security

✗ HTTPS

✓ SPF

✗ DMARC

Details

Company number

0832.604.943

VAT number

BE 0832.604.943

Registered office

Galileilaan 15, 2845 Niel

Names & denominations

OXYPOINT

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Opening faillissement

Start date

6 January 2011

Peppol

Not registered

Contact

oxypoint.eu [email protected]

Activities · NACE

Groothandel in farmaceutische en medische artikelen

Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

Verhuur en lease van medisch en paramedisch materieel

Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

View on CBE Public ↗ Annual accounts (NBB) ↗

OXYPOINT

Warning lights

Financials

What happened to OXYPOINT?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Website

Technologies

Hosting & Email

Domain

Website info

Features

Security

Details

Frequently asked questions